Crossject Société Anonyme (EPA:ALCJ)
France
· Delayed Price · Currency is EUR 0.9251
-0.0345 (-3.60%)
Apr 29, 2025, 11:39 AM CET
Crossject Société Anonyme Revenue
In the year 2024, Crossject Société Anonyme had annual revenue of 4.12M EUR with 6.28% growth. Crossject Société Anonyme had revenue of 2.53M in the half year ending December 31, 2024, a decrease of -38.10%.
Revenue
4.12M
Revenue Growth
+6.28%
P/S Ratio
11.14
Revenue / Employee
38.82K
Employees
106
Market Cap
45.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.12M | 243.00K | 6.28% |
| Dec 31, 2023 | 3.87M | -3.19M | -45.18% |
| Dec 31, 2022 | 7.06M | 583.00K | 9.00% |
| Dec 31, 2021 | 6.48M | 1.64M | 33.77% |
| Dec 31, 2020 | 4.84M | -58.27K | -1.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |